Home › Funds › KLINGENSTEIN FIELDS & CO LP › JNJ

KLINGENSTEIN FIELDS & CO LP position in JNJ

JOHNSON & JOHNSON · Health Care

KLINGENSTEIN FIELDS & CO LP reported holding 216,905 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$57.4M, representing 2.02% of its reported portfolio and ranking #16 among its reported holdings. KLINGENSTEIN FIELDS & CO LP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)216.91K sh
Reported value held$57.42M
Portfolio Weight2.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How KLINGENSTEIN FIELDS & CO LP's JNJ position evolved

KLINGENSTEIN FIELDS & CO LP first disclosed a stake in JNJ in Q3 2023 at 268,979 shares (US$41.9M). The position peaked in Q3 2026 at 216,905 shares, worth US$57.4M. Across 13 filings, KLINGENSTEIN FIELDS & CO LP increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 216,905 shares valued at US$57.4M — a reduction of -1,489 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 268.98K $41.89M New
Q4 2023 256.25K $40.16M Reduce
Q1 2024 249.56K $39.48M Reduce
Q2 2024 247.01K $36.10M Reduce
Q3 2024 244.97K $39.70M Reduce
Q4 2024 242.20K $35.03M Reduce
Q1 2025 241.51K $40.05M Hold
Q2 2025 229.56K $35.06M Reduce
Q3 2025 227.06K $42.10M Reduce
Q4 2025 225.68K $46.70M Reduce
Q1 2026 221.53K $54.15M Reduce
Q2 2026 218.39K $55.47M Reduce
Q3 2026 216.91K $57.42M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has KLINGENSTEIN FIELDS & CO LP held JNJ?

KLINGENSTEIN FIELDS & CO LP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KLINGENSTEIN FIELDS & CO LP's current position in JNJ?

As of Q3 2026, KLINGENSTEIN FIELDS & CO LP holds 216.91K shares of JNJ (JOHNSON & JOHNSON), valued at $57.42M, representing 2.02% of its reported portfolio and ranking #16.

Has KLINGENSTEIN FIELDS & CO LP been buying or selling JNJ?

In the latest 13F filing (Q3 2026), KLINGENSTEIN FIELDS & CO LP reduced its position in JNJ. The position peaked in Q3 2026 at 216.91K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.